Dovepress Open Access to Scientific and Medical Research Open Access Full Text Article Chronic Obstructive Pulmonary Disease as an Independent Risk Factor for Cardiovascular Morbidity
暂无分享,去创建一个
[1] J. Leikauf,et al. Comparisons of Self‐Reported and Chart‐Identified Chronic Diseases in Inner‐City Seniors , 2009, Journal of the American Geriatrics Society.
[2] A. Anzueto,et al. Impact of statins and ACE inhibitors on mortality after COPD exacerbations , 2009, Respiratory research.
[3] J. Davies,et al. Monitoring respiratory disease severity in cystic fibrosis. , 2009, Respiratory care.
[4] R. Luben,et al. Respiratory Function as a Marker of Bone Health and Fracture Risk in an Older Population , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[5] U. Ekelund,et al. Obesity Is Associated With Altered Lung Function Independently of Physical Activity and Fitness , 2009, Obesity.
[6] P. Barnes,et al. A comparison of respiratory conditions between multiple race adults and their single race counterparts: an analysis based on American Indian/Alaska Native and white adults , 2008, Ethnicity & health.
[7] C. Furberg,et al. Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. , 2008, JAMA.
[8] A. Pickard,et al. Risk for Death Associated with Medications for Recently Diagnosed Chronic Obstructive Pulmonary Disease , 2008, Annals of Internal Medicine.
[9] J. Pankow,et al. Cross-Sectional and Prospective Study of Lung Function in Adults With Type 2 Diabetes , 2008, Diabetes Care.
[10] N. Anthonisen,et al. Cardiovascular morbidity and the use of inhaled bronchodilators , 2008, International journal of chronic obstructive pulmonary disease.
[11] L. Egede. Major depression in individuals with chronic medical disorders: prevalence, correlates and association with health resource utilization, lost productivity and functional disability. , 2007, General hospital psychiatry.
[12] Peter H Edwards,et al. Arterial stiffness and osteoporosis in chronic obstructive pulmonary disease. , 2007, American journal of respiratory and critical care medicine.
[13] N. Yıldırım,et al. Pulmonary function in multiple sclerosis without any respiratory complaints , 2007, Clinical Neurology and Neurosurgery.
[14] Marta Benet,et al. Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort study. , 2007, American journal of respiratory and critical care medicine.
[15] B. Hedblad,et al. Reduced lung function predicts increased fatality in future cardiac events. A population‐based study , 2006, Journal of internal medicine.
[16] J. Spertus,et al. Impact of Chronic Obstructive Pulmonary Disease on Post-Myocardial Infarction Outcomes: P201 , 2006, The American journal of cardiology.
[17] S. Anker,et al. Neurohumoral activation as a link to systemic manifestations of chronic lung disease. , 2005, Chest.
[18] A. Hansell,et al. Patterns of comorbidities in newly diagnosed COPD and asthma in primary care. , 2005, Chest.
[19] S. Suissa,et al. Cardiovascular morbidity and mortality in COPD. , 2005, Chest.
[20] S. Sidney,et al. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. , 2005, Chest.
[21] Fernando Holguin,et al. Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001. , 2005, Chest.
[22] D. Sin,et al. The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. , 2005, Chest.
[23] J. Erikssen,et al. Lung function, smoking and mortality in a 26-year follow-up of healthy middle-aged males , 2005, European Respiratory Journal.
[24] JoAnn E Manson,et al. Chronic obstructive pulmonary disease, asthma, and risk of type 2 diabetes in women. , 2004, Diabetes care.
[25] A Senthilselvan,et al. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis , 2004, Thorax.
[26] R. Burnett,et al. Cardiovascular Mortality and Long-Term Exposure to Particulate Air Pollution: Epidemiological Evidence of General Pathophysiological Pathways of Disease , 2003, Circulation.
[27] Duanping Liao,et al. Lung function and incident coronary heart disease: the Atherosclerosis Risk in Communities Study. , 2003, American journal of epidemiology.
[28] L. Egede,et al. Racial/ethnic differences in influenza vaccination coverage in high-risk adults. , 2003, American journal of public health.
[29] L. Gordis,et al. Assessment of a national health interview survey-based method of measuring community socioeconomic status. , 2003, Annals of epidemiology.
[30] C. O'Donnell,et al. Body composition and resting energy expenditure in clinically stable, non-weight-losing patients with severe emphysema. , 2003, Chest.
[31] S. Ramsey,et al. The burden of illness and economic evaluation for COPD , 2003, European Respiratory Journal.
[32] X. Busquets,et al. Systemic effects of chronic obstructive pulmonary disease , 2003, European Respiratory Journal.
[33] T. Assimes,et al. Inhaled short acting β agonist use in COPD and the risk of acute myocardial infarction , 2003, Thorax.
[34] S. Antoniu,et al. Hospitalizations and mortality in the Lung Health Study , 2002, Expert review of pharmacoeconomics & outcomes research.
[35] W. Bailey,et al. Editorial: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines for COPD, Including COVID-19, Climate Change, and Air Pollution , 2023, Medical science monitor : international medical journal of experimental and clinical research.
[36] D. Mannino. COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. , 2002, Chest.
[37] L. Kuller,et al. Coronary Artery Calcification in Older Adults to Age 99: Prevalence and Risk Factors , 2001, Circulation.
[38] T. Ezzati-Rice,et al. Comparison of NIS and NHIS/NIPRCS vaccination coverage estimates. National Immunization Survey. National Health Interview Survey/National Immunization Provider Record Check Study. , 2001, American journal of preventive medicine.
[39] T. Truelsen,et al. Lung function and risk of fatal and non-fatal stroke. The Copenhagen City Heart Study. , 2001, International journal of epidemiology.
[40] M. Thun,et al. Methodological issues in estimating smoking-attributable mortality in the United States. , 2000, American journal of epidemiology.
[41] B. Hedblad,et al. Respiratory Decline in Smokers and Ex-Smokers — An Independent Risk Factor for Cardiovascular Disease and Death , 2000, Journal of cardiovascular risk.
[42] B. Psaty,et al. The Risk of Myocardial Infarction Associated with Inhaled β -Adrenoceptor Agonists , 2000 .
[43] P. Stein,et al. Heart Rate Variability Reflects Severity of COPD in PiZ α1-Antitrypsin Deficiency , 1998 .
[44] R. Gillum,et al. Validity of self-reported hypertension in the National Health and Nutrition Examination Survey III, 1988-1991. , 1997, Preventive medicine.
[45] D. Mannino,et al. Obstructive lung disease deaths in the United States from 1979 through 1993. An analysis using multiple-cause mortality data. , 1997, American journal of respiratory and critical care medicine.
[46] E. Vartiainen,et al. Symptoms of chronic bronchitis and the risk of coronary disease , 1996, The Lancet.
[47] B. Lipworth,et al. Abnormal myocardial repolarisation in response to hypoxaemia and fenoterol. , 1995, Thorax.
[48] N. Keenan,et al. The validity of self-reported hypertension and correlates of hypertension awareness among blacks and whites within the stroke belt. , 1995, American journal of preventive medicine.
[49] K R Westerterp,et al. Resting energy expenditure in patients with chronic obstructive pulmonary disease. , 1991, The American journal of clinical nutrition.
[50] Massey Jt,et al. Design and estimation for the National Health Interview Survey 1985-94. , 1989 .
[51] S. Harlow,et al. Agreement between questionnaire data and medical records. The evidence for accuracy of recall. , 1989, American journal of epidemiology.
[52] D. Boudreau,et al. Cardiovascular events associated with ipratropium bromide in COPD. , 2010, Chest.
[53] J. Maurer. Impact of Chronic Obstructive Pulmonary Disease on Post-Myocardial Infarction Outcomes , 2009 .
[54] Judith K Jones,et al. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. , 2006, Annals of epidemiology.
[55] D. Sin,et al. Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality. , 2005, Proceedings of the American Thoracic Society.
[56] S. Rennard. Clinical approach to patients with chronic obstructive pulmonary disease and cardiovascular disease. , 2005, Proceedings of the American Thoracic Society.
[57] D. Hunninghake. Cardiovascular disease in chronic obstructive pulmonary disease. , 2005, Proceedings of the American Thoracic Society.
[58] D. Sin,et al. Chronic obstructive pulmonary disease: a novel risk factor for cardiovascular disease. , 2005, Canadian journal of physiology and pharmacology.
[59] T. Petty. Definition, epidemiology, course, and prognosis of COPD. , 2003, Clinical cornerstone.
[60] A. An. Performing Logistic Regression on Survey Data with the New SURVEYLOGISTIC Procedure , 2002 .
[61] S. Oparil,et al. The National Health and Nutrition Examination Survey III: How Are We Doing with Blood Pressure Control? , 2000 .
[62] M. Feinleib,et al. VITAL and HEALTH STATISTICS , 2000 .
[63] B. Psaty,et al. The risk of myocardial infarction associated with inhaled beta-adrenoceptor agonists. , 2000, American journal of respiratory and critical care medicine.
[64] National Health Interview Survey: research for the 1995-2004 redesign. , 1999, Vital and health statistics. Series 2, Data evaluation and methods research.
[65] P. Stein,et al. Heart rate variability reflects severity of COPD in PiZ alpha1-antitrypsin deficiency. , 1998, Chest.
[66] M. Sears. Bronchodilators and acute cardiac death. , 1997, American journal of respiratory and critical care medicine.
[67] N. Breslow,et al. Statistical methods in cancer research: volume 1- The analysis of case-control studies , 1980 .